SCHEMBL5555646

SCHEMBL5555646

CCOC(=O)O.CCOC1C=Cc2ccccc2N1C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.67
LMNA P02545 1/20 0.67
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
GAA P10253 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPK1 P28482 3/20 0.38
P2RX4 Q99571 6/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
TSHR P16473 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
P2RX1 P51575 3/20 0.36
P2RX3 P56373 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL367474 0.80 SMN1; SMN2 (1.00) SMN1; SMN2LMNAMEN1KMT2AGAA
SCHEMBL338 0.80 SMN1; SMN2 (1.00) SMN1; SMN2LMNAMEN1KMT2AGAA
SCHEMBL23705539 0.80 SMN1; SMN2 (1.00) SMN1; SMN2LMNAMEN1KMT2AGAA
SCHEMBL29367804 0.80 SMN1; SMN2 (1.00) SMN1; SMN2LMNAMEN1KMT2AGAA
SCHEMBL30563642 0.79 SMN1; SMN2 (0.78) SMN1; SMN2LMNAMEN1KMT2AMAPK1
SCHEMBL4742545 0.79 SMN1; SMN2 (0.78) SMN1; SMN2LMNAMEN1KMT2AMAPK1
SCHEMBL4357939 0.77 SMN1; SMN2 (0.67) SMN1; SMN2LMNAMEN1KMT2AGAA
Carbimide SCHEMBL10800076 0.76 SMN1; SMN2 (0.90) SMN1; SMN2LMNAMEN1KMT2AGAA
1,2-Dichloroethane SCHEMBL28697158 0.76 SMN1; SMN2 (0.90) SMN1; SMN2LMNAMEN1KMT2AGAA
SCHEMBL11386321 0.76 SMN1; SMN2 (0.54) SMN1; SMN2LMNAMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1519756-B1 USE OF METAL COMPLEXES CONTAINING PERFLUOROALKYL AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING FOR REPRESENTING INTRAVASCULAR THROMBI BAYER SCHERING PHARMA AG (DE) 2007-05-02 EP disclosed